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This Meeting Review describes the proceedings and conclusions from the inaugural meeting of the Electron
Microscopy Validation Task Force organized by the Unified Data Resource for 3DEM (http://www.
emdatabank.org) and held at Rutgers University in New Brunswick, NJ on September 28 and 29, 2010. At
the workshop, a group of scientists involved in collecting electron microscopy data, using the data to deter-
mine three-dimensional electron microscopy (3DEM) density maps, and building molecular models into the
maps explored how to assess maps, models, and other data that are deposited into the Electron Microscopy
Data Bank and Protein Data Bank public data archives. The specific recommendations resulting from the
workshop aim to increase the impact of 3DEM in biology and medicine.Introduction: Background and Goals of the Meeting
3DEM andMolecular Modeling Based on 3DEMData Are
Well-Established
Structure analysis of macromolecular complexes using three-
dimensional electron microscopy (3DEM) has become an essen-
tial tool for structural biology research. 3DEM is uniquely able
to determine the structural organization of macromolecular
complexes not amenable to othermethods (Frank, 2006; Glaeser
et al., 2007). More than thirty years ago, low-dose imaging and
computational averagingof imagesof two-dimensional (2D) crys-
tals of bacteriorhodopsin produced a density map that revealedStructure 20, Feprotein a helices spanning the lipid bilayer (Henderson and Un-
win, 1975). Subsequent advances in 3DEM of unstained speci-
mens embedded in vitreous ice (cryo-EM) are increasingly
yielding density maps of a wide variety of specimens at near-
atomic resolution. Applications to icosahedral viruses and chap-
eronins already demonstrate that 3DEM maps can be good
enough to trace Ca backbones de novo and to visualize some
side-chain densities without the aid of X-ray crystallography
(Chen et al., 2011; Liu et al., 2010; Zhang et al., 2010a, 2010b).
3DEM is unusually versatile and can be used to investigate the
structures of a wide variety of specimens under conditions closebruary 8, 2012 ª2012 Elsevier Ltd 205Open access under CC BY license.
Figure 1. EMDataBank, Unified Data Resource for 3DEM Home Page
Available at http://emdatabank.org.
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homogeneous molecular complexes to heterogeneous confor-
mations and may assume different forms with or without
symmetry. Subnanometer resolution cryo-EM structures are
found to be increasingly useful in providing illustrative snapshots
of macromolecular machines such as the ribosome, chapero-
nins, and viruses bound to various cellular effectors or ligands
(Becker et al., 2009; Frank et al., 1995; Miyazawa et al., 2003;
Zhang et al., 2010b). Finally, electron tomography, in which
a series of images is collected from a region of the specimen
tilted to different viewing angles, can be used to obtain 3D
density maps of individual macromolecular particles, including
pleiomorphic ones for which whole-particle averaging is inad-
missible (Gru¨newald et al., 2003), as well as sections, or even
whole cells, provided they are not thicker than approximately
0.7 mm (Al-Amoudi et al., 2004, 2007; Frank, 2006; McIntosh,
2007; Medalia et al., 2002). For an extensive review of 3DEM
procedures, see Baker and Henderson (2012).
Interpretation of a 3DEM density map frequently involves
building a molecular model. Models may consist of atoms or
‘‘coarse-grained’’ objects representing multiple atoms, such as
whole residues, secondary structure segments, and shape-
based features. A model of a given macromolecular complex is
often computed by assembling experimentally determined
atomic structures or homologymodels of the individual subunits.
The subunit models can either be held rigid (Chapman, 1995;
Jiang et al., 2001; Lasker et al., 2009; Roseman, 2000; Ross-206 Structure 20, February 8, 2012 ª2012 Elsevier Ltd Open access undermann, 2000; Volkmann and Hanein, 1999; Wriggers et al.,
1999; Wriggers and Chaco´n, 2001) or allowed to flex (Fabiola
and Chapman, 2005; Rusu et al., 2008; Schro¨der et al., 2007;
Tama et al., 2004; Topf et al., 2005, 2008; Trabuco et al., 2008;
Trabuco et al., 2011; Wriggers et al., 2000; Zhang et al., 2011)
while being fit into the map; precautions need to be taken to
avoid over-fitting by introducing too many refinable parameters
relative to the data available. At higher resolutions (better than
6 A˚ for a mostly a-helical structure or 4 A˚ for a mostly b-stranded
structure), it may be possible to recognize known folds of protein
subunits (Jiang et al., 2001; Khayat et al., 2010; Saha et al.,
2010). In addition to density map features and protein stereo-
chemistry, modeling may also utilize other types of information,
such as symmetry, protein proximities from proteomics experi-
ments, residue proximities from chemical cross-linking, related
homologous structures, and SAXS profiles (Alber et al., 2008).
Increasingly, 3DEM maps and models described in the
literature are deposited in public archives, where they can be
retrieved for independent assessment, use, and development of
new tools for visualization, fitting, and validation. EMDataBank,
the Unified Data Resource for 3DEM (http://emdatabank.org;
Lawson et al., 2011; Figure 1), provides joint deposition and
retrieval of maps in the Electron Microscopy Data Bank
(EMDB) archive as well as coordinates of the models fitted into
map volumes in the Protein Data Bank (PDB) archive. Currently,
more than 1,000 EM maps and more than 400 map-derived
models are available (Figure 2). CC BY license.
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Figure 2. 3DEM Entries in EMDB and PDB,
Cumulative by Year
Statistics for December 31, 2011: 1322 map entries, 427
model entries.
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Every 3DEM map and model has some uncertainty. Therefore,
an assessment of map and model errors is essential, especially
when a wide range of techniques are used by a variety of prac-
titioners. In addition, as with all rapidly developing fields, in our
enthusiasm to go further and faster, there is a risk that avoidable
mistakes, both large and small, may be made in the production
or interpretation of maps. Such mistakes may have the adverse
effect of undermining the credibility of 3DEMmethods in general.
It is therefore important to develop methods for checking our
conclusions and validating maps and models, with the goal of
establishing a set of best practices for the field.
Historically, the3DEMfieldhasnotmadeanynotoriousblunders
but, as with all scientific disciplines, a handful of papers have
reported erroneous results. While the rarity of these incidents is
heartening, they do provide good justification for being cautious.
In the early days of electron crystallography, the resolution of
published projection maps was sometimes overly optimistic
(Hayward and Stroud, 1981) before the importance of correcting
for beam tilt was realized (Henderson et al., 1986). It has also
proved remarkably easy to get the absolute hand wrong even in
subnanometer resolution structures (Bo¨ttcher et al., 1997; Ku¨hl-
brandt and Wang, 1991; Li et al., 1997; Zhou et al., 2000). Images
of tilted anduntilted specimens togetherprovideall the information
needed to correctly determine this property (Belnap et al., 1997;
Cheng et al., 2002; Conway et al., 1997).
In the single particle electron microscopy field, five papers
between 2002 and 2005 independently reported different
structures of the same receptor complex, the 1.3 MDa inositol
phosphate receptor, a tetramer responsible for calcium release
from the endoplasmic reticulum. Two of the structures were
determined in negative stain and three in amorphous ice (da Fon-
seca et al., 2003; Hamada et al., 2003; Jiang et al., 2002; Sato
et al., 2004; Serysheva et al., 2005). Although the differences
between the maps may be partly explained by differences in
biochemical preparation, they are more likely due to errors in
the structure determination. A more recent cryo-EM study at
10 A˚ (Ludtke et al., 2011b), while being substantially different
from the three earlier cryo-EM maps, agrees qualitatively with
one of the negative stain structures (Hamada et al., 2003), so
there is evidence of convergence. Although each of these
studies used methods that were the best available at the time,
the absence of appropriate validation tools has meant that it
was not possible either to prove the structures were correct or
to show they were incorrect.Structure 20, February 8, 2012 ªAdditionally, it is common practice to fit
crystal structures or homology models into
cryo-EM maps. A discrepancy in model-based
interpretation of the 2.5MDa ryanodine receptor
remains unresolved and illustrates the challenge
in fittingmolecular fragments into low-resolution
maps (Serysheva et al., 2008; Tung et al., 2010).
In the earlier study, a homology model wasdocked into the map region indicated by antibody labeling, while
in the other study, global fitting with an X-ray structure of a
fragment was performed. These differences in the protocol
were sufficient to completely alter the final model and illustrate
the need to not only identify the best-fitting location for a frag-
ment and determine a confidence interval, but to also consider
possible conformational variability of the fragment being
docked.
Given the current rapid increase in the size, productivity, and
impact of the 3DEM community, it is timely to suggest guidelines
for validating, annotating, and depositing 3DEM maps and
map-derivedmodels. There is an opportunity to synergize exper-
imental and computational efforts by bringing together the
respective communities. There is a need to establish standards
as well as to share software and databases. Similar efforts in
the X-ray crystallography (Read et al., 2011), nuclear magnetic
resonance (NMR) spectroscopy (http://www.wwpdb.org/
workshop/2010/nmr_validation.html), and modeling communi-
ties (Schwede et al., 2009) can serve as constructive examples.
Meeting Aims
Twenty eight participants from 19 academic institutions world-
wide attended a meeting at Rutgers on September 28 and 29,
2010 (http://vtf.emdatabank.org). The participants discussed
issues in the computation and validation of 3DEM maps and
models as well as ways to strengthen the collaboration between
the experimental and modeling communities. The participants’
consensus was formulated as specific recommendations, aimed
to increase the impact of 3DEM in biology and medicine.
Meeting Program
On the first day, 14 presentations focused on computing maps
from raw 3DEM data, and computing molecular models from
maps were given. On the second day, independent ‘‘map’’ and
‘‘model’’ discussion groups were asked to address specific
questions related to the deposition and validation of 3DEM
maps and models, respectively, report on their findings, and
make recommendations for the future. These two discussion
groups are referred to as the Map Group and the Model Group
respectively throughout the rest of this review.
We now summarize the consensus of recommendations
reached among the participants of the meeting. The recommen-
dations are concerned with derivation, annotation, archiving,
visualization, distribution, and publication of EM maps and
models based on the maps. These recommendations are in-
tended to be a starting point for further refinement by a broader
community of scientists interested in EM.2072012 Elsevier Ltd Open access under CC BY license.
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The Map Group’s discussion began by enumerating the attri-
butes of a 3DEM map, among the most important of which are
the method used to prepare the sample and the symmetry of
the object examined.
The sample can be prepared in many different ways, but here
we describe the four most frequently used techniques. First,
negatively stained samples are usually prepared by adsorption
onto a carbon film, followed by washing with a few drops of
negative stain, such as 1%uranyl acetate, and then dried, result-
ing in images where the molecules of interest are seen as low-
density regions from which the stain has been excluded.
Second, ice-embedded samples are normally prepared by blot-
ting a thin film of a solution containing the molecules of interest,
then plunge-freezing the film into liquid ethane at a temperature
just above its freezing point (Dobro et al., 2010; Dubochet et al.,
1988). The images in this case show the structures as regions of
higher density against a background of vitreous ice. Third,
samples, often 2D crystals, can also be deposited on a contin-
uous carbon film and embedded in ice or a medium other than
ice or negative stain, such as glucose, trehalose, or tannic acid
(Unwin and Henderson, 1975). This treatment frequently
preserves the high-resolution diffraction order, but contrast
matching at low resolution can obscure the molecular envelope.
Finally, sections of tissue or other specimens can be prepared
either by plastic embedding (Glauert and Lewis, 1998) or high
pressure freezing and cryo-sectioning (Ladinsky, 2010), followed
by tomographic data collection and 3D structure determination.
Plastic embedding requires care in interpretation due to possible
fixation artifacts, and cryo-sectioning can produce compression
artifacts; nonetheless, both are widely used and valuable
methods.
The nature of themaps that are computed from 2D EM images
depends principally on the symmetry of the objects being exam-
ined. Thus, there are maps for 2D crystal structures that can be
obtained using either crystallographic methods (Henderson
et al., 1986) or single-particle approaches (Frank et al., 1988);
maps for helical structures that can be obtained using either
Fourier-Bessel methods (Diaz et al., 2010) or single-particle
approaches (Egelman, 2010); single-particle maps, including
structures with icosahedral symmetry, other point group
symmetries or no symmetry (Rochat and Chiu, 2012); and finally
tomogram and sub-tomogram average maps (Schmid and
Booth, 2008).
Standards for Assessing Resolution and Accuracy
of Maps Need to Be Developed
It is clear that the community needs validation methods for as-
sessing the accuracy of 3DEM maps. A satisfactory validation
method does not yet exist, and its development remains an
open research problem. However, there are a number of condi-
tions that are necessary for map validity, as well as some
methods that may detect whether a map is incorrect under
certain circumstances. The majority of these methods require
at least a 3D reconstruction without any post-processing, such
as masking or filtration. Most of these methods also require
access to some portion of the raw data and metadata used to
produce the reconstruction. A few methods require collection
of additional data explicitly for validation. Examples of some
validation methods are given below.208 Structure 20, February 8, 2012 ª2012 Elsevier Ltd Open access underAbsolute Hand Determination. The absolute hand of a struc-
ture cannot be determined without either a tilt experiment or
sufficient resolution to resolve chiral features directly in the
map. Tilt experiments also offer the opportunity to validate the
accuracy of the structure as a whole and can help place limits
on orientation accuracy. Such methods include random-conical
tilt (Radermacher, 1988), orthogonal tilt (Leschziner and No-
gales, 2006), single-particle tomography (Baumeister et al.,
1999), and tilt-pair parameter plots (Henderson et al., 2011;
Rosenthal and Henderson, 2003) for which a web-based service
is available (https://cryoem.nimr.mrc.ac.uk/software/). The
absolute hand can often be established by comparison of the
structures of component subunits whose hands have been
determined previously. The availability of structures in a number
of such subunits, or subunit domains within a complex, can
validate or correct the hand determination (Baker et al., 2003;
Kanamaru et al., 2002; Leiman et al., 2004). In addition, the
hand of an icosahedral capsid with chiral surface lattice (such
as T = 7l) can be easily distinguished at low resolution by the
arrangement of hexameric capsomeres in images of freeze-frac-
ture, metal shadowed particles (Prasad et al., 1993).
Data Coverage and Agreement between Raw Images and
Class Averages. Additional validation methods used in single-
particle reconstruction include ensuring agreement between
projections of the 3D structure and raw images or (if generated)
class-averages, ensuring that reference-free class-averages are
fully represented among the set of model projections, and
ensuring sufficient coverage of particle orientations (Orlova
et al., 1996; Tang et al., 2007). These criteria represent necessary
but not sufficient criteria for a reliable 3D reconstruction.
Statistical Assessment of the Map. Map variance and local
resolution determination, such as bootstrap-based variance
maps (Penczek et al., 2006) and local Fourier Shell Correlation
(FSC) measurements (Me´ne´tret et al., 2007), can provide addi-
tional measures to help interpret structures. For maps with reso-
lution better than 20 A˚ by the 0.5 FSC criterion, RMEASURE
(Sousa and Grigorieff, 2007) can be used to estimate resolution
and signal-to-noise directly from the map based on correlation
of neighboring Fourier Transform terms. Possible bias from a
starting model or overfitting of noise should also be estimated
and statistics provided where possible.
Recommendation. Experimentalists should be encouraged
to assess their own maps according to the criteria listed above
and report the methods that they used when depositing the
maps. To help the community as a whole, EMDataBank should
develop a table of existing map validation techniques with
a description of what experimental data are required for each
technique, the circumstances under which the technique can
be used, the software package(s) (with links) that implement
the technique, and what aspect of the reconstruction the tech-
nique validates. This table can be updated as new methods
are developed. Any published method should be considered
as a candidate for inclusion in the list, as the list would not
mandate any tests to be performed, but simply present possible
tools available for authors to validate their own data. As methods
are tested on a variety of data sets, the fieldwill begin to establish
which techniques are reliable for each specific task. Additionally,
EMDataBank should gather and provide raw benchmark data
that would enable the community to test the methods. CC BY license.
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Structural Features Should Be in Accordance
with the Claimed Resolution
The single-particle map resolution is typically evaluated accord-
ing to the FSC of two maps constructed from independent data
sets (Penczek, 2010b). However, the threshold value for the map
resolution has not been uniformly reported (Rosenthal and Hen-
derson, 2003). Because of various experimental and computa-
tional factors that lead to damping of the Fourier amplitudes of
the images, the final density map needs to be scaled to retrieve
the detailed features (Bo¨ttcher et al., 1997). One method is to
apply a Gaussian function equivalent to a temperature factor in
X-ray crystallography (Ferna´ndez et al., 2008; Rosenthal and
Henderson, 2003); anothermethod is to apply a one-dimensional
structure factor obtained from the X-ray scattering or a model
(Baker et al., 2010; Gabashvili et al., 2000; Penczek, 2010a). At
resolution better than 4.5 A˚, the helical pitch and b strand sepa-
ration should be visible in addition to some bulky side-chains. At
subnanometer resolution, secondary structure features, such as
long a helices and large b sheets, should begin to emerge.
Several existing tools allow quantitative assessment of
secondary structure (Baker et al., 2007; Kong et al., 2004). If
the level of secondary structure visible in themap does not agree
with the cited resolution and the sequence-based structure
prediction, the resolution estimate may not be accurate. At lower
resolution (10–20 A˚), the situation is more complex and requires
more care. In some favorable situations, domain or molecular
boundaries may be delineated. At still lower resolution (>20 A˚),
a simple point-spread function plot may be adequate, along
with a statement of the RMS noise level, estimated from
presumed featureless regions (Fan and Ellisman, 2000).
Recommendation. Deposition of a published map should
include its full FSC curve to the Nyquist frequency on a linear
spatial-frequency scale (Frank, 2006, see pages 250 and 251).
If the final experimental volume was masked in any way, FSC
curves should be provided for both the masked and unmasked
versions. If the half-datasets compared in FSC were separated
at the outset of analysis, this should be stated; otherwise, it will
be assumed that a less independent comparison in which the
whole data set was aligned against a common model was per-
formed. Intermediate levels of independence between the gold
standard of carrying out two completely independent analyses
and common 3D model throughout should also be described.
Reconstruction software packages should include the option
to produce an unmasked map after the last cycle of refinement.
Map manipulations and transformations other than magnifica-
tion and contrast transfer function correction should also be re-
ported. Examples includedensity stretching (e.g., negativedensity
truncation), high- and low-pass filtering, sharpening, signal-to-
noise ratio weighting, thresholding, damping (e.g., FOM weight-
ing), cropping, and masking. The key parameters in different
reconstruction algorithms should be reported. In addition, the
quantitative assessment of the map features, such as segmenta-
tion and feature extraction, should be included in the deposition.
Map Symmetry Should Be Validated
Many 3DEM specimens are composed of multiple copies of the
same proteins, and thus, symmetry may exist in the complex.
However, the symmetry may break down for different functional
states. Reconstruction may be carried out with or withoutStructure 20, Fsymmetry imposed; this treatment needs to be explicitly re-
ported and justified.
Recommendation. A program is required to read in the
density map, recognize any point group, helical or translational
symmetry, and print out the point group or helical or space group
symmetry, and the precise origin. This processing would ensure
that the stated symmetry is real and that the stated origin is
correct. The program would ideally also provide the transforma-
tion to reorient a map into the standard coordinate frame for the
point group or helical symmetry (Heymann et al., 2005; Lawson
et al., 2008).
Map Depositions Should Include Annotations Specific
to Each Map Type
3DEM map types can be classified as 2D crystal, helical array,
single-particle, tomogram, and sub-tomogram average. The
reconstruction algorithms are unique to each of these speci-
mens/map types, and thus the corresponding annotations are
unique.
Recommendation. For each specimen/map category, there
should be clear definitions for what data are deposited, and
these are outlined as follows.
2D Crystal Maps. The following data should be deposited:
structure factor file following X-ray crystallographic conventions
and including the space group, symmetry applied, raw intensities
(I), anderror estimates (sI) if electrondiffractiondata are available;
amplitudes (A), phases (4),sA,s4 if only imagedata areavailable;
map A, 4, and figure of merit if both diffraction data and image
data are available; any information about twinning if present;
and a 3D map. There should be an option to deposit merged A,
4 lists, such as those produced by LATLINE (Agard, 1983). If the
2D images have been processed using single-particle methods,
the single-particle deposition procedure can be used (below). In
addition, point group symmetries should be indicated when
they exist, including cyclic Cn and/or dihedral Dn symmetries.
Helical Maps. Helical filaments and tubes are currently being
reconstructed by Fourier-Bessel and single-particle approaches
with different data requirements for deposition. In both cases,
a helically-symmetric 3D volume needs to be submitted, and
the orientation of the helical symmetry axis must be noted as
well as the coordinates of this axis. For the Fourier-Bessel
methods, the layer line data decomposed into complex G(R)
functions (containing amplitudes and phases as a function of
the distance R from the meridian of the transform [Klug et al.,
1958]) should be deposited in one of two forms. The first form is
the conventional form of Gn,l(R), where n is the Bessel order and
l is the layer line number. The helical repeat c needs to be entered
in A˚, and the units/turn (u/t) should be entered as a ratio of two
integers. The second form is the more general form of Gn,Z(R),
where n is the Bessel order and Z is the spacing (in A˚1 from
the equator). The axial rise per subunit should be entered (in A˚),
and the u/t should be entered as a real number. The convention
is that negative values of n correspond to left-handed helices.
For the single-particle approaches, the screw symmetry (axial
rise in A˚ and rotation in degrees per subunit) must be described,
with the convention that negative angles correspond to a left-
handed helix. The same resolution and Eulerian angle statistics
as proposed for single particles below should be deposited.
Single-ParticleMaps. Single-particlemaps includemapswith
icosahedral, other point group symmetries, and no symmetry.209ebruary 8, 2012 ª2012 Elsevier Ltd Open access under CC BY license.
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following additional information should be supplied: the quality
of the raw data (experimental B-factor of the raw images and
data processing); methods for initial map generation and for iter-
ative map refinement, including full description of any imposed
or no symmetry; particle orientation (Eulerian angle) distribution
coverage; statistical confidence of the map (variance map);
methods of map sharpening, masking, and filtering; FSC curves
or other resolution estimates; and handedness determination
method. If the deposited map has been manually masked by the
authors, both the unmasked andmaskedmaps should be depos-
ited. In addition, validation statistics from the raw map produced
by the reconstruction software should also be provided. If the
maphasbeensegmented, thesegmentationshouldbedeposited.
If extra averaging has been done within an asymmetric unit (e.g.,
for T = 13 icosahedral symmetry), the fully averaged sub-volume
should be deposited. Other useful data include the power spec-
trum inside and outside a soft mask as well as raw tilt pair images
and tilt pair parameter plots.
Tomograms. The tomographic approach is especially well-
suited for studying pleomorphic single particles of biological
assemblies, organelles, and whole cells. The resolution of a
tomogram is difficult to assess, though a quantitative measure
of the alignment of images in a tilted series can be determined.
RMS deviation of fiducial gold particles between frames in
a tomographic series is one good indicator for tomogram quality.
The deposition should include the respective reconstructions
from the tilt series, and, if available, segmentation volumes/
masks. The tilt series angular coverage and spacing, the name
of the reconstruction algorithm, and estimates of the alignment
error, such as fiducial marker RMS information, should also be
deposited. An estimate of the reconstruction resolution, such
as that obtained from the noise-compensated leave-one-out
method, where (e.g., FSC = 0.5) resolution is plotted against
the tilt angle of the frame (Cardone et al., 2005) and an estimate
of the non-isotropic point-spread function showing the expected
vertical and in-plane resolution, should also be included. Better
measures of resolution and reliability need to be developed.
Sub-Tomogram Averages. Sub-tomogram extraction, sort-
ing, aligning, and averaging has become a routine approach to
determine 3D structures of conformationally identical compo-
nents at a higher resolution. It is imperative that a standard
assessment in termsof resolutionandmap reliability isdeveloped.
Thedepositeddata should include thefinal averagedmap that ap-
peared in the publication. Validation statistics should be gener-
ated for the raw averaged volume created from the sub-volumes
without filtration or masking. The total number of sub-volumes/
particles should be stated, along with an FSC curve for the sub-
volumes used, and the tilt series angular coverage and spacing
should be provided. Finally, the reconstruction algorithms that
were used to create the tomogram, to align it in 3D, to classify
the sub-volumes, and to create the average should be identified.
The Requirements and Practicalities for the Archiving
of Raw 3DEM Data Files Should Be Investigated
Raw 2D images and raw unmasked maps are needed for many
validation processes, as described above. There is mixed
opinion on the archiving of the raw images because of the size
and the logistics of the data transfer and storage. For example,
a single set of raw single-particle EM particle image data might210 Structure 20, February 8, 2012 ª2012 Elsevier Ltd Open access undercontain 20,000 particles in 5003 500 boxes, totaling 5GB, using
a byte image format. A raw cryo-EM tomographic series might
contain 70 frames of 2K 3 2K pixels, so 280 MB; a complete
tomogram would be 2K 3 2K 3 256, so 1–3 GB. Furthermore,
to make such data meaningful, the metadata that describe
important microscope parameters, such as the microscope
model used, kV, Cs, Cc, aperture sizes, illumination conditions,
energy filter settings, magnification, defocus, astigmatism,
beam tilt if determined, beam convergence/divergence, and tilt
angles, must be defined.
Recommendation. Tools operating on raw data should be
made available to individual laboratories to enable reporting of
validation results. EMDataBank should investigate the practical-
ities of archiving raw images and describe the metadata as well
as the storage capabilities that would be required.
While it is currently impractical to archive raw images from all
publicly archived EM reconstructions due to size (e.g. > 1TB for
some projects), we recommend that a portal be established to
archive selected raw image datasets. Since several labs have
already made their raw data publicly accessible, the portal can
simply serve as a pointer to those sites. The availability of raw
image datasets will facilitate development of improved image-
processing procedures (LeBarron et al., 2008; Shaikh et al.,
2008) as well as improved molecular modeling algorithms.
Recommendations by the Modeling Group
The Modeling Group discussion began by enumerating four
important attributes of macromolecular assembly models based
on EM data.
First, representations of a model with different degrees of
granularity can be used. Each ‘‘particle’’ in a model may repre-
sent an atom, a side-chain centroid, a small contiguous cluster
of atoms, a domain, or even a whole protein (Alber et al.,
2008). In addition, secondary structure elements (Baker et al.,
2007) and segments of the map (Pintilie et al., 2010; Wriggers
et al., 1998, 2010) can be represented by a variety of geometrical
objects. Representations other than those using one particle per
atom are frequently referred to as coarse-grained, reduced, or
multi-scale (Grubisic et al., 2010; Kolinski, 2011).
Second, the degrees of freedom explored in a search for
a model that best fits a map can vary. The explored degrees of
freedom depend on the representation and can be further limited
by the sampling algorithm. For example, in rigid body fitting, only
the position and orientation of the subunit model are computed,
but in flexible fitting, the model conformation as well as position
and orientation are computed. For maps with sufficiently high
resolution, de novo models can be generated. The distinction
between flexible, rigid body, and de novo fitting is important
for assessing the signal-to-noise ratio and/or data-to-parameter
ratio as well as for distinguishing between the precision (vari-
ability among the well-scoring models) and accuracy (closeness
to the truth) of a fitted model. The number of refinable parame-
ters and available data need to be considered to avoid over-
fitting.
Third, different types of information in addition to the 3DEM
map can be used to augment the generation of a model. For
example, a subunit model can be derived either completely (in
rigid fitting) or partly (in flexible fitting) by other means, including
X-ray crystallography NMR spectroscopy, and with a lesser CC BY license.
Structure
Meeting Reviewaccuracy by SAXSmeasurement, comparativemodeling, and ab
initio structure prediction. Moreover, the relationships between
subunits can be informed by complementary data, such as pro-
teomics experiments, chemical cross-linking, a related homolo-
gous assembly structure, or a SAXS profile (Lasker et al., 2010;
Robinson et al., 2007).
Fourth, either a single set of model coordinates or an
ensemble of model coordinates (as is frequently the case for
reporting NMR-based structures) can be produced to reflect
the ambiguity in the coordinates, given the input data.
Frequently, the variability in the ensemble is meant to represent
the precision of themodel and represents the lower bound on the
error. As an alternative to an ensemble of models, the precision
can be represented, for example, by variation for each coordi-
nate in a single model.
These four attributes can, in principle, vary across different
parts of the model. It should ideally be possible to provide a hier-
archical representation (i.e., multiple representations applied to
the same component of the assembly) as well as different repre-
sentations for different components. For example, one subunit
may be determined at high resolution while another subunit
could be represented as a sphere if no atomic structure is
known.
Criteria for Assessing Models Must Be Established
The usefulness of a model strongly depends on its accuracy;
different applications that use the models have varied require-
ments for model accuracy and precision. As with structural
models derived by other techniques, accuracy can be estimated
globally for the whole model or locally for each specific part (e.g.,
residue). There are three sets of fundamentally different criteria
for assessing amodel based on a 3DEMmap, all of which should
generally be satisfied.
First, the conformation of a subunit and interfaces between
subunits can be assessed without regard to the 3DEM map.
The corresponding criteria for assessment of the internal
consistency of a model with known molecular constraints
(e.g., on geometry, conformation, and molecular interactions)
include those proposed by the PDB working groups focused
on assessment of crystallographic (Read et al., 2011), NMR
(http://www.wwpdb.org/workshop/2010/nmr_validation.html),
and modeled (Schwede et al., 2009) structures.
Second, a model can be assessed with regard to the 3DEM
map. A sample set of corresponding criteria for agreement of
the model with the map are produced by the EMFIT program
(Rossmann, 2000, 2001), including atomic clashes, component
interactions, chemical properties, fit to the map, as well as
a composite criterion that quantifies model quality relative to
a background distribution. Other programs that provide statis-
tical measures for assessing a model in the context of a 3DEM
map include CoAn (Volkmann, 2009) and E2HSTAT (available
in EMAN2, Ludtke et al., 1999). A correlation coefficient between
amap determined by EMand amap calculated from amodel can
also be used (Jiang et al., 2001; Pintilie et al., 2010; Wriggers and
Chaco´n, 2001), as can residue-based and overall real-space R
values (Bra¨nde´n and Jones, 1990). Comparisons of the cross-
correlation to other metrics, such as those borrowing from
machine learning techniques, enable systematic and objective
evaluation of scoring functions (Vasishtan and Topf, 2011).
More studies on the evaluation tools themselves are needed.Structure 20, FeFinally, amodel can be assessedwith regard to additional data
about the structure that were not used inmodel calculation. Such
data may include cross-linking, antibody labeling, sites of
specific labels (such as carbohydrate moieties), proximity of
known features to recognizable positions in the map, chemical
properties consistent with the environment, and spectroscopic
measurements.
Assessment criteria should be as independent as possible
from the objective function that is optimized during fitting (Kley-
wegt, 2009). At low resolution, a large number of non-EM-
derived constraints are typically used in model construction,
potentially reducing the informative value of certain assessment
criteria. For example, analysis of themain-chain stereochemistry
of a rigid-body fitted structure has no bearing on the accuracy
and quality of the obtained model, but rather reflects the quality
of the high-resolution structure that was used to fit the low-reso-
lution data. Consideration of the modeling and fitting procedures
is therefore an important component of the assessment.
Methods for estimating model accuracy are being developed;
no accurate or dominant method has yet emerged. There is
a great need to assess the model quality based on the data-
to-parameter ratio and precision, but anecdotal evidence
suggests that such methods are not yet reliable. Approaches
that begin to address this issue include cross-validation
(Schro¨der et al., 2010) and quantifying the best-fitting model
relative to alternative fits (Tung et al., 2010; Vasishtan and
Topf, 2011; Volkmann and Hanein, 1999; Volkmann, 2009; Wrig-
gers and Birmanns, 2001) or the fitting to the mirror image map
(Rossmann, 2000). The predicted accuracy should depend on
the map variance. In assessing the quality of a map, all of these
criteria need to be satisfied within reasonable tolerance. The
EMFIT program copes with this problem by taking the average
of each attribute expressed as the number of standard devia-
tions above the mean of random fits (Rossmann et al., 2001).
It also needs to be determined whether or not a map computed
from a flexibly fitted model fits within the error bars of the original
map equally well as the original model (if it does, there is no infor-
mation in the map to justify flexible fitting). The Bayesian inferen-
tial structure determination approach originally proposed for
NMR structure determination (Rieping et al., 2005) could also
be applied to EM-based modeling. Finally, accuracy measures
that convey the suitability of models for specific applications
need to be established.
Recommendation. We recommend coordinated develop-
ment of model assessment criteria and corresponding software,
with special emphasis on criteria reflecting the suitability of
models for specific end-user applications. EMDataBank should
provide a technical platform to make validated tools for esti-
mating model accuracy available to the users of the models; it
should also establish a mechanism for continuous evaluation
and improvement of these tools.
Community-wide Benchmarks for Modeling Methods
Need to Be Created
With a growing number of density maps and models, it is urgent
that a clear set of standards be established for benchmarking ex-
isting and new modeling techniques. In addition to a publically
available benchmark data set, it will also be necessary to estab-
lish an open community forum to report the algorithm and results
used in the various modeling approaches.211bruary 8, 2012 ª2012 Elsevier Ltd Open access under CC BY license.
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ciation of quality criteria as well as development of methods for
modeling based on 3DEM maps in the first place, we recom-
mend establishment of community-wide benchmarks of cases
with experimentally determined 3DEM maps and known struc-
tures (e.g., from X-ray crystallography). Then, the correlation
between quality criteria and actual geometrical accuracy can
be determined empirically. The Cryo-EM Modeling Challenge
effort (Ludtke et al., 2011a) will be helpful in this regard, as well
as establishing a prototype modeling web-portal. If possible,
these benchmark cases should also include ‘‘raw’’ micrograph
(particle) images.
Sequences of All Components Need to Be Annotated
Recommendation. We recommend that both ‘‘biological’’ and
modeled subunit sequences be clearly defined in map-derived
models. Even when the biological sequence is known (e.g., it
may be preferred to fit an X-ray structure of a homolog instead
of a homology model of the ‘‘biological’’ sequence when the
confidence in a homology model is lower than in the X-ray struc-
ture), deposition of a subunit model with the sequence different
from the biological sequence should be allowed. Finally, if
known, subunit sequences should be listed for a 3DEM map
even if there is not a molecular model for them.
Capability to Archive Coarse-Grained Representations
of Models Is Needed
As discussed, not all 3DEM models contain atomistic represen-
tations of proteins. In some cases, such as de novo models in
which Ca backbone traces are constructed, one point or pseu-
doatom may represent an entire amino acid residue. In other
instances, pseudoatoms may be used for flexible fitting of
coarse-grained features or simple geometrical description of
secondary structure, or even a whole protein subunit can be
used in annotating the macromolecular structure.
Recommendation. We recommend that PDB consider
generalizing the representations of molecular models that can
be deposited to account for the variety of possible model
representations. Ideally, a general representation scheme and
the corresponding file format would be used for derivation, anno-
tation, archiving, visualization, distribution, and publication of
models.
Standards for Data Formats Must Be Established
to Facilitate Data and Software Exchange
Although the crystallographic and NMR spectroscopy communi-
ties have essentially reached a consensus on the definition of
common data formats that enable the seamless exchange of
data and algorithms (Westbrook and Fitzgerald, 2003; Winn,
2003), most software tools for building models based on 3DEM
maps use proprietary data formats for input data, parameters,
and results. Although data formats from experimental structures
can be applied to the protein model coordinates, data types
specific to 3DEM-based modeling and specific details of the
individual modeling algorithms frequently vary between different
applications. This incompatibility is a serious impediment to the
exchange of tools and algorithms; it hinders both method devel-
opment and thewidespread use of tools outside of the developer
groups themselves.
Recommendation. We recommend that EMDataBank
initiate a community-wide mechanism for reaching an agree-
ment on a common open data format for information related to212 Structure 20, February 8, 2012 ª2012 Elsevier Ltd Open access undemolecular modeling based on 3DEM data with the aim of facili-
tating the exchange of algorithms and data.
General Recommendations
Journals Should Encourage Map and/or Model
Deposition before Publication
At the present time, models are published with widely varying
levels of descriptive information about how they were derived.
A set of guidelines for what should be included in a paper needs
to be established. These guidelines should be shared with jour-
nal editors and reviewers. We encourage journals to require
proof of map and/or model deposition before publication.
Models that have been peer reviewed and referred to in pub-
lished literature should be publicly available. Without access to
the model coordinates and sufficient annotation of the model,
it is impossible for the reader to evaluate the results and to
assess the validity of published interpretations.
Recommendation. We recommend that EMDataBank, in
collaboration with the 3DEM community, suggest standards for
journal publication, define minimum annotation standards, and
establish the scope and requirements of a public archive of
models based on EM maps.
EMDataBank Can Play a Key Role
The discussion at the Workshop explored how to maximize the
impact of the 3DEM public data archives.
Recommendation. We recommend that EMDataBank
consortium members work together with the 3DEM community
to provide unified access to molecular models and their annota-
tions and support the development of data standards to facilitate
exchange of information and algorithms. EMDataBank should
play an active role in facilitating discussions about data stan-
dards between developers of computational methods and their
users, provide access to tools for estimating model accuracy,
and promote their further development. Its user interface should
allow a broad range of queries to the model database as well as
links to experimental data. Tools for estimating model errors and
selecting the likely best model among the available models
should be included. An interface to interactive model evaluation
services should be established. Mechanisms to notify users
when a particular sequence is modeled (or experimental data
becomes available) should be implemented. The EMDataBank
consortium should work to establish a series of online docu-
ments with community feedback to explain the value and
limitations of protein structure models based on EM data. The
3DEM public data archives should be as inclusive of all method
developers and modeling methods as technically feasible.
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